I am hoping to see atleast one of them going live before end of this quarter, considering the revenue for engineering and implemtation has started ramping up. The sheer size of these companies will ensure that once they start rolling out the new products to different geographies with Bodytel as the sole platform, it will create a snowball effect. Beurer itself when I Last checked has around 60-80 product variations alone. Roche - anti coagulation device alone has a massive market share. Just got to be patient and top up when price dips.
$4-5mil EV with revenue accelerating, plenty of cash and billion dollar clients - upside is huge.
Add to My Watchlist
What is My Watchlist?
